Search
Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies.
Read about a new CAR T cell therapy now approved for marginal zone lymphoma (MZL).
Meet Jaap-Jan “J. J.” Boelens, who joined MSK Kids in 2018 as Chief of the Stem Cell Transplantation and Cell Therapy Service.
MSK nurses reaffirm their commitment to healing in the "Blessing of Hands" ceremony.
The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD, chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK), as their President-Elect for 2020–2021.
MSK launched the Kravis Women in Science Endeavor (WiSE) in 2020 to pledge a commitment to support gender equity in science. The winners will be recognized at the annual Kravis WiSE Symposium which is held every year during Women’s History Month.
Memorial Sloan Kettering Cancer Center has recruited Sohrab Shah, PhD, to serve as the inaugural Chief of Computational Oncology within the Department of Epidemiology and Biostatistics. In this role, Dr. Shah will lead the effort to build a research program dedicated to harnessing MSK’s numerous “Big Data” resources to translate biologic knowledge to clinical practice.
MSK Kids is leading a major effort to fully deliver on the promise of precision medicine for our youngest patients.
Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.
Learn how cancer patients benefit from carefully considered design at Memorial Sloan Kettering, from the director of its design team.